SARS-CoV-2: Pathogenesis, and Advancements in Diagnostics and Treatment
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
SARS-CoV-2: Pathogenesis, and Advancements in Diagnostics and Treatment
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 11, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-10-06
DOI
10.3389/fimmu.2020.570927
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak
- (2020) Hussin A. Rothan et al. JOURNAL OF AUTOIMMUNITY
- The deadly coronaviruses: The 2003 SARS pandemic and the 2020 novel coronavirus epidemic in China
- (2020) Yongshi Yang et al. JOURNAL OF AUTOIMMUNITY
- Composition and divergence of coronavirus spike proteins and host ACE2 receptors predict potential intermediate hosts of SARS-CoV-2
- (2020) Zhixin Liu et al. JOURNAL OF MEDICAL VIROLOGY
- Baricitinib as potential treatment for 2019-nCoV acute respiratory disease
- (2020) Peter Richardson et al. LANCET
- Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding
- (2020) Roujian Lu et al. LANCET
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
- (2020) Chaolin Huang et al. LANCET
- A pneumonia outbreak associated with a new coronavirus of probable bat origin
- (2020) Peng Zhou et al. NATURE
- Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia
- (2020) Qun Li et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
- (2020) Daniel Wrapp et al. SCIENCE
- The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2
- (2020) Nature Microbiology
- Insights into the Recent 2019 Novel Coronavirus (SARS-CoV-2) in Light of Past Human Coronavirus Outbreaks
- (2020) Hossam M. Ashour et al. Pathogens
- Symptom Criteria for COVID‐19 Testing of Heath Care Workers
- (2020) Brian M Clemency et al. ACADEMIC EMERGENCY MEDICINE
- Autopsy Findings and Venous Thromboembolism in Patients With COVID-19
- (2020) Dominic Wichmann et al. ANNALS OF INTERNAL MEDICINE
- The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade
- (2020) B. Coutard et al. ANTIVIRAL RESEARCH
- Development of CRISPR as an Antiviral Strategy to Combat SARS-CoV-2 and Influenza
- (2020) Timothy R. Abbott et al. CELL
- Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2
- (2020) Vanessa Monteil et al. CELL
- Elevated exhaustion levels and reduced functional diversity of T cells in peripheral blood may predict severe progression in COVID-19 patients
- (2020) Hong-Yi Zheng et al. Cellular & Molecular Immunology
- Prominent changes in blood coagulation of patients with SARS-CoV-2 infection
- (2020) Huan Han et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- A Comparative Study on the Clinical Features of Coronavirus 2019 (COVID-19) Pneumonia With Other Pneumonias
- (2020) Dahai Zhao et al. CLINICAL INFECTIOUS DISEASES
- Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China
- (2020) Chuan Qin et al. CLINICAL INFECTIOUS DISEASES
- Off-label use of tocilizumab for the treatment of SARS-CoV-2 pneumonia in Milan, Italy
- (2020) Valentina Morena et al. European Journal of Internal Medicine
- High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study
- (2020) Julie Helms et al. INTENSIVE CARE MEDICINE
- Teicoplanin: an alternative drug for the treatment of COVID-19?
- (2020) Sophie Alexandra Baron et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial
- (2020) Philippe Gautret et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- The SARS-CoV-2 outbreak: What we know
- (2020) Di Wu et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma
- (2020) Chenguang Shen et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Evaluation of Nucleocapsid and Spike Protein-Based Enzyme-Linked Immunosorbent Assays for Detecting Antibodies against SARS-CoV-2
- (2020) Wanbing Liu et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Covid‐19 and the digestive system
- (2020) Sunny H Wong et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Arbidol monotherapy is superior to lopinavir/ritonavir in treating COVID-19
- (2020) Zhen Zhu et al. JOURNAL OF INFECTION
- The effect of corticosteroid treatment on patients with coronavirus infection: a systematic review and meta-analysis
- (2020) Zhenwei Yang et al. JOURNAL OF INFECTION
- Arbidol combined with LPV/r versus LPV/r alone against Corona Virus Disease 2019: A retrospective cohort study
- (2020) Lisi Deng et al. JOURNAL OF INFECTION
- Evolutionary analysis of SARS-CoV-2: how mutation of Non-Structural Protein 6 (NSP6) could affect viral autophagy
- (2020) Domenico Benvenuto et al. JOURNAL OF INFECTION
- Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy
- (2020) Ning Tang et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial
- (2020) Ivan Fan-Ngai Hung et al. LANCET
- COVID-19 and Italy: what next?
- (2020) Andrea Remuzzi et al. LANCET
- Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
- (2020) Yeming Wang et al. LANCET
- COVID-19: consider cytokine storm syndromes and immunosuppression
- (2020) Puja Mehta et al. LANCET
- Isolation of SARS-CoV-2-related coronavirus from Malayan pangolins
- (2020) Kangpeng Xiao et al. NATURE
- A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19
- (2020) Bin Cao et al. NEW ENGLAND JOURNAL OF MEDICINE
- Reply to Kesici et al. and Zeng et al.: Blocking the virus and reducing the inflammatory damage in COVID-19
- (2020) Kai Duan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Effective treatment of severe COVID-19 patients with tocilizumab
- (2020) Xiaoling Xu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Publisher Correction: A human monoclonal antibody blocking SARS-CoV-2 infection
- (2020) Chunyan Wang et al. Nature Communications
- Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France
- (2020) Matthieu Million et al. Travel Medicine and Infectious Disease
- Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: open label, randomised controlled trial
- (2020) Wei Tang et al. BMJ-British Medical Journal
- Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection
- (2020) Xin Zou et al. Frontiers of Medicine
- Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19)
- (2020) Tao Guo et al. JAMA Cardiology
- Smoking Upregulates Angiotensin-Converting Enzyme-2 Receptor: A Potential Adhesion Site for Novel Coronavirus SARS-CoV-2 (Covid-19)
- (2020) Samuel James Brake et al. Journal of Clinical Medicine
- Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro
- (2020) Jia Liu et al. Cell Discovery
- Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study
- (2020) Qingxian Cai et al. Engineering
- The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro
- (2020) Leon Caly et al. ANTIVIRAL RESEARCH
- Increased CD95 (Fas) and PD‐1 expression in peripheral blood T lymphocytes in COVID‐19 patients
- (2020) Silvia Bellesi et al. BRITISH JOURNAL OF HAEMATOLOGY
- Compassionate Use of Tocilizumab for Treatment of SARS-CoV-2 Pneumonia
- (2020) Stanley C Jordan et al. CLINICAL INFECTIOUS DISEASES
- Use of Baricitinib in Patients with Moderate and Severe COVID-19
- (2020) Boghuma K Titanji et al. CLINICAL INFECTIOUS DISEASES
- Effect of Systemic Glucocorticoids on Mortality or Mechanical Ventilation in Patients With COVID-19
- (2020) Marla J Keller et al. Journal of Hospital Medicine
- Ribavirin, Remdesivir, Sofosbuvir, Galidesivir, and Tenofovir against SARS-CoV-2 RNA dependent RNA polymerase (RdRp): A molecular docking study
- (2020) Abdo A. Elfiky LIFE SCIENCES
- No evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe COVID-19 infection
- (2020) J.M. Molina et al. MEDECINE ET MALADIES INFECTIEUSES
- Dexamethasone in Hospitalized Patients with Covid-19 — Preliminary Report
- (2020) NEW ENGLAND JOURNAL OF MEDICINE
- The prevalence of symptoms in 24,410 adults infected by the novel coronavirus (SARS-CoV-2; COVID-19): A systematic review and meta-analysis of 148 studies from 9 countries
- (2020) Michael C. Grant et al. PLoS One
- Incidence of thrombotic complications in critically ill ICU patients with COVID-19
- (2020) F.A. Klok et al. THROMBOSIS RESEARCH
- Diagnostic accuracy of serological tests for covid-19: systematic review and meta-analysis
- (2020) Mayara Lisboa Bastos et al. BMJ-British Medical Journal
- COVID-19 infection: Origin, transmission, and characteristics of human coronaviruses
- (2020) Muhammad Adnan Shereen et al. Journal of Advanced Research
- Acute fibrinolysis shutdown occurs early in septic shock and is associated with increased morbidity and mortality: results of an observational pilot study
- (2019) Felix Carl Fabian Schmitt et al. Annals of Intensive Care
- Severe Acute Respiratory Syndrome Coronavirus Viroporin 3a Activates the NLRP3 Inflammasome
- (2019) I-Yin Chen et al. Frontiers in Microbiology
- An E460D substitution in the NS5 protein of tick-borne encephalitis virus confers resistance to the inhibitor Galidesivir (BCX4430) and also attenuates the virus for mice
- (2019) Ludek Eyer et al. JOURNAL OF VIROLOGY
- Effect of Vitamin C Infusion on Organ Failure and Biomarkers of Inflammation and Vascular Injury in Patients With Sepsis and Severe Acute Respiratory Failure
- (2019) Alpha A. Fowler et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Innate Immune Evasion by Human Respiratory RNA Viruses
- (2019) Marjolein Kikkert Journal of Innate Immunity
- The human coronavirus HCoV‐229E S‐protein structure and receptor binding
- (2019) Zhijie Li et al. eLife
- CAR T Cells Beyond Cancer: Hope for Immunomodulatory Therapy of Infectious Diseases
- (2019) Michelle Seif et al. Frontiers in Immunology
- Challenges of convalescent plasma infusion therapy in Middle East respiratory coronavirus infection: a single centre experience
- (2018) Jae-Hoon Ko et al. ANTIVIRAL THERAPY
- Extracellular Matrix Metalloproteinase Inducer EMMPRIN (CD147) in Cardiovascular Disease
- (2018) Saskia von Ungern-Sternberg et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- MERS-CoV: Understanding the Latest Human Coronavirus Threat
- (2018) et al. Viruses-Basel
- Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease
- (2018) Maria L. Agostini et al. mBio
- A planarian nidovirus expands the limits of RNA genome size
- (2018) Amir Saberi et al. PLoS Pathogens
- Biology of IL-38 and its role in disease
- (2017) Frank L. van de Veerdonk et al. IMMUNOLOGICAL REVIEWS
- The endothelium in hypoxic pulmonary vasoconstriction
- (2017) Benjamin Grimmer et al. JOURNAL OF APPLIED PHYSIOLOGY
- Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymerase
- (2017) Yousuke FURUTA et al. PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES
- Coagulation and sepsis
- (2017) Marcel Levi et al. THROMBOSIS RESEARCH
- Inflammation biomarkers in blood as mortality predictors in community-acquired pneumonia admitted patients: Importance of comparison with neutrophil count percentage or neutrophil-lymphocyte ratio
- (2017) Jose Curbelo et al. PLoS One
- Membrane particles generated from mesenchymal stromal cells modulate immune responses by selective targeting of pro-inflammatory monocytes
- (2017) Fabiany da C. Gonçalves et al. Scientific Reports
- Th1 versus Th2 T cell polarization by whole-cell and acellular childhood pertussis vaccines persists upon re-immunization in adolescence and adulthood
- (2016) Tara Bancroft et al. CELLULAR IMMUNOLOGY
- Interleukin-1 Receptor Blockade Is Associated With Reduced Mortality in Sepsis Patients With Features of Macrophage Activation Syndrome
- (2016) Bita Shakoory et al. CRITICAL CARE MEDICINE
- Airway Memory CD4 + T Cells Mediate Protective Immunity against Emerging Respiratory Coronaviruses
- (2016) Jincun Zhao et al. IMMUNITY
- Inflammasomes and its importance in viral infections
- (2016) Gaurav Shrivastava et al. IMMUNOLOGIC RESEARCH
- Glycopeptide Antibiotics Potently Inhibit Cathepsin L in the Late Endosome/Lysosome and Block the Entry of Ebola Virus, Middle East Respiratory Syndrome Coronavirus (MERS-CoV), and Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV)
- (2016) Nan Zhou et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Prognostic Significance of Neutrophil-to-Lymphocyte Ratio in Patients with Sepsis: A Prospective Observational Study
- (2016) Xuan Liu et al. MEDIATORS OF INFLAMMATION
- Inactivated Mesenchymal Stem Cells Maintain Immunomodulatory Capacity
- (2016) Franka Luk et al. STEM CELLS AND DEVELOPMENT
- Lopinavir/ritonavir in the treatment of HIV-1 infection: a review
- (2016) Jonathan Shuter Therapeutics and Clinical Risk Management
- Sofosbuvir plus ribavirin for treatment of hepatitis C virus in patients co-infected with HIV (PHOTON-2): a multicentre, open-label, non-randomised, phase 3 study
- (2015) Jean-Michel Molina et al. LANCET
- T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial
- (2015) Daniel W Lee et al. LANCET
- Autophagy postpones apoptotic cell death in PRRSV infection through Bad-Beclin1 interaction
- (2015) Ao Zhou et al. Virulence
- Middle East respiratory syndrome coronavirus (MERS-CoV): animal to human interaction
- (2015) Ali S. Omrani et al. Pathogens and Global Health
- Evaluation of Ebola Virus Inhibitors for Drug Repurposing
- (2015) Peter B. Madrid et al. ACS Infectious Diseases
- Arbidol as a broad-spectrum antiviral: An update
- (2014) Julie Blaising et al. ANTIVIRAL RESEARCH
- Coronavirus NSP6 restricts autophagosome expansion
- (2014) Eleanor M Cottam et al. Autophagy
- Treatment With Anti-C5a Antibody Improves the Outcome of H7N9 Virus Infection in African Green Monkeys
- (2014) Shihui Sun et al. CLINICAL INFECTIOUS DISEASES
- The Biological Function and Clinical Utilization of CD147 in Human Diseases: A Review of the Current Scientific Literature
- (2014) Lijuan Xiong et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Phase I safety trial of intravenous ascorbic acid in patients with severe sepsis
- (2014) Alpha A Fowler et al. Journal of Translational Medicine
- Ribavirin and interferon alfa-2a for severe Middle East respiratory syndrome coronavirus infection: a retrospective cohort study
- (2014) Ali S Omrani et al. LANCET INFECTIOUS DISEASES
- CCR5 Gene Disruption via Lentiviral Vectors Expressing Cas9 and Single Guided RNA Renders Cells Resistant to HIV-1 Infection
- (2014) Weiming Wang et al. PLoS One
- Coronavirus membrane-associated papain-like proteases induce autophagy through interacting with Beclin1 to negatively regulate antiviral innate immunity
- (2014) Xiaojuan Chen et al. Protein & Cell
- Nuclear localization of dengue virus (DENV) 1–4 non-structural protein 5; protection against all 4 DENV serotypes by the inhibitor Ivermectin
- (2013) M.Y.F. Tay et al. ANTIVIRAL RESEARCH
- Pharmacokinetics and Pharmacodynamics of Recombinant Human Angiotensin-Converting Enzyme 2 in Healthy Human Subjects
- (2013) Manuel Haschke et al. CLINICAL PHARMACOKINETICS
- Revised mechanism of complement lectin-pathway activation revealing the role of serine protease MASP-1 as the exclusive activator of MASP-2
- (2012) D. Heja et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Neutralizing human monoclonal antibodies to severe acute respiratory syndrome coronavirus: target, mechanism of action, and therapeutic potential
- (2011) Melissa M. Coughlin et al. REVIEWS IN MEDICAL VIROLOGY
- Coronaviruses Hijack the LC3-I-Positive EDEMosomes, ER-Derived Vesicles Exporting Short-Lived ERAD Regulators, for Replication
- (2010) Fulvio Reggiori et al. Cell Host & Microbe
- Neutralizing epitopes of the SARS-CoV S-protein cluster independent of repertoire, antigen structure or mAb technology
- (2010) Jody D. Berry et al. mAbs
- IL-37 is a fundamental inhibitor of innate immunity
- (2010) Marcel F Nold et al. NATURE IMMUNOLOGY
- The significance of OX40 and OX40L to T-cell biology and immune disease
- (2009) Michael Croft et al. IMMUNOLOGICAL REVIEWS
- Evasion by Stealth: Inefficient Immune Activation Underlies Poor T Cell Response and Severe Disease in SARS-CoV-Infected Mice
- (2009) Jincun Zhao et al. PLoS Pathogens
- Host CD147 blockade by small interfering RNAs suppresses growth of human colon cancer xenografts
- (2008) Dietmar Abraham Frontiers in Bioscience-Landmark
- A critical function for CD200 in lung immune homeostasis and the severity of influenza infection
- (2008) Robert J Snelgrove et al. NATURE IMMUNOLOGY
- A critical link between Toll-like receptor 3 and type II interferon signaling pathways in antiviral innate immunity
- (2008) H. Negishi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- SARS coronavirus and innate immunity
- (2007) Matthew Frieman et al. VIRUS RESEARCH
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started